Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.A VACCINE for cocaine addiction may be tested for the first time on humans this summer, and trials for a vaccine for nicotine addiction could follow.
A US company, ImmuLogic Pharmaceuticals, based in Massachusetts, has developed both vaccines. Trials on laboratory rats have reduced the addictive potential of cocaine by as much as 50 per cent. Researchers believe that the vaccine, used in conjunction with support services, could eliminate addicts' craving for the drug.
Cocaine has an immediate and powerful effect on the brain because its very small molecules can easily penetrate the blood-brain barrier. The vaccine attaches an antibody to the cocaine molecule, making it too large to pass easily through the barrier.
Researchers forced rats to become addicted to cocaine and trained them to self-administer more of the drug by pulling on a lever. They then vaccinated some of the rats. Although a substantial amount of cocaine still reached the brain in some cases, the vaccinated rats eventually stopped pulling on the levers.
The researchers are also trying to ensure that the vaccine will not lead addicts to change to other drugs, will not have an effect on the central nervous system and will be able to go through the placenta to provide protection for a foetus.
But Dr Barbara Fox, a senior researcher at ImmuLogic, points out that the vaccine would need to be accompanied by counselling and psychological support in case addicts tried to overcome the effects of the antibodies - for example, by increasing their intake of cocaine.
Human trials could begin in June or July if the US Food and Drug Administration gives the go-ahead. About four million people in the US are addicted to cocaine, or its derivative crack cocaine, for which the vaccine could also be used. It could be available within five years if trials are successful.
Dr Fox and her team are also working on a nicotine vaccine, but it may be next year before human trials begin. Nicotine is regarded as the most addictive drug: 100,000 people in Britain die each year from smoking- related diseases.
Subscribe to Independent Premium to bookmark this article
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments